AMY VAN T BUI
MISSION VIEJO, CA NPI 1013027838
Browse related groups: CA Abbott Laboratories All categories
General Payments — all program years on this page
$8,413.37
- Category: General Payments
- Program years: PY2018–2024
- Record count: 423
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,299.85 across 62 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,299.85 | 62 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $334.93 | 15 |
| Lilly USA, LLC | $134.45 | 8 |
| ABBVIE INC. | $115.82 | 5 |
| SANOFI-AVENTIS U.S. LLC | $80.18 | 4 |
| Novo Nordisk AS | $73.96 | 4 |
| RECORDATI_RARE_DISEASES_INC. | $67.07 | 3 |
| Amgen Inc. | $65.45 | 3 |
| Corcept Therapeutics | $61.35 | 2 |
| Radius Health, Inc. | $60.30 | 3 |
| Kyowa Kirin, Inc. | $53.14 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $44.37 | 2 |
| Tandem Diabetes Care, Inc. | $43.38 | 2 |
| Alexion Pharmaceuticals, Inc. | $29.03 | 1 |
| Verity Pharmaceuticals Inc. | $23.73 | 1 |
| Medtronic, Inc. | $23.02 | 1 |
| CeQur Corporation | $21.90 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.31 | 1 |
| MannKind Corporation | $17.52 | 1 |
| DEXCOM, INC. | $17.48 | 1 |
| Currax Pharmaceuticals LLC | $13.46 | 1 |
By program year
Records — PY2024 (62)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.